+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-09-27Number of Pages: 144

Single-use Bioprocessing Systems Market - (Product - Bioreactors & Fermenters, Mixers, Bags, Bioprocess Containers, Filtration Devices, Tubing, Sampling Systems, Connectors & Clamps, Probes & Sensors; End User - Pharmaceutical, Biotechnology, CRO & CMO, and Academic & Research Institutes; Application - Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, and Patient Specific Cell Therapies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Single-use Bioprocessing Systems Market: Snapshot 

The global single-use bioprocessing systems market has witnessed impressive growth over the years. Experts in the industry have observed a noticeable shift in adoption patterns of small biotechnology startups and biopharmaceutical organizations toward single-use technologies. As the biopharmaceutical industry nears maturation, organizations are progressively focusing on finding innovative treatment solutions that are not only different from their competitors, but also have a reduced pipeline for development. 

Transparency Market Research estimates that the global single-use bioprocessing systems market will expand at a robust CAGR of 11.1% over the forecast period. Escalating at this pace, the market is projected to rise from a value of US$2.3 bn in 2015 to US$5.9 bn by 2024.

bioprocessing systems market

Monoclonal Antibody Production Leads with Maximum Market Share by Application

The single-use bioprocessing systems market, by application, is driven by the high demand for biologics for the treatment of cancer, autoimmune disorders, rare diseases, and infectious diseases in the past few years.

Globally, the monoclonal antibody production segment is likely to exhibit a high CAGR from 2016 to 2024, accounting for a 66.0% share by the end of the forecast period. Monoclonal antibody production is driven by the recent rise in the number of monoclonal antibodies in clinical trial stages. The segment is also fueled by recent US FDA and EU approvals for monoclonal antibodies. Both Europe and the U.S. approved approximately 10 antibody therapeutics in 2015, which has led to the segment capturing the maximum market share. The developed regions in Asia Pacific have greater vaccination needs and a higher burden of cancer and cardiovascular diseases. This fuels the monoclonal antibody production segment. The segment is poised for high growth due to best applicability of single-use bioreactors for mammalian cell culture.

Growth in APAC Single-use Bioprocessing Systems Market to be Higher than Global Average

In terms of market share, Europe and North America led the single-use bioprocessing systems market in 2015 and are projected to retain their dominance throughout the forecast period. This can be attributed to the fact that CROs and CMOs as well as niche biotechnology and multiproduct biopharmaceutical companies in this region have been early adopters of single-use bioprocessing technologies compared to their counterparts in emerging markets. The leadership in terms of revenue is likely to sustain due to cutting-edge research and development in biologics being centered in these regions. It has been postulated that the purchase of single-use bioprocessing systems will be higher in regions that lay greater emphasis on innovation and where developments in bioscience are clustered. Moreover, many leading vendors are headquartered in North America and Europe, where they have higher share of p sales. This supports the growth of the single-use bioprocessing systems market.

Asia Pacific has a booming biotechnology and biopharmaceutical industry and several pharmaceutical companies have been providing contract research services to CROs and CMOs in India and China. Furthermore, the burden of cancer and infectious diseases is greater in developing countries compared to the developed world, which implies that the disease-burdened population is at a higher need for new cancer therapies and vaccines. Single-use bioprocessing systems will aid in addressing these unmet needs. The market in Asia Pacific is set to expand at a rate higher than the global average during the forecast period.

Key companies operating in the global single-use bioprocessing systems market include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Single-use Bioprocessing Systems Market

Chapter 4. Market Overview
4.1. Introduction & Overview of Processes
4.2. Comparison : Single-use Vs. Stainless Steel Systems
4.3. Regulatory Scenario
4.4. Key Industry Developments
4.5. Average Pricing Analysis
4.6. Market Dynamics
       4.6.1. Drivers
       4.6.2. Restraints
       4.6.3. Opportunity
4.7. Value Chain Analysis
4.8. Porter’s Five Forces Analysis
4.9. Value Chain Analysis

Chapter 5. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Product
5.1. Key Findings
5.2. Introduction
5.3. Market Size (US$ Mn) Forecast, by Product
       5.3.1. Bioreactors
       5.3.2. Mixers
       5.3.3. Bags
       5.3.4. Tubing
       5.3.5. Filtration Devices
       5.3.6. Bioprocess Containers
       5.3.7. Sampling Systems
       5.3.8. Connectors & Clamps
       5.3.9. Probes & Sensors
5.4. Market Attractiveness Analysis, by Product, 2015
5.5. Key Trends

Chapter 6. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Application 
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Application
       6.3.1. Monoclonal Antibody Production 
       6.3.2. Vaccine Production 
       6.3.3. Plant Cell Cultivation
       6.3.4. Patient Specific Cell Therapies
       6.3.5. Others (recombinant proteins, enzymes etc.)
6.4. Market Attractiveness Analysis, by Application, 2015
6.5. Key Trends

Chapter 7. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by End-user 
7.1. Key Findings
7.2. Introduction
7.3. Market Size (US$ Mn) Forecast, by End-user
       7.3.1. Pharmaceutical
       7.3.2. Biotechnology 
       7.3.3. CRO & CMO 
       7.3.4. Academic & Research Institutes
7.4. Market Attractiveness Analysis, by End-user, 2015
7.5. Key Trends

Chapter 8. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Region
       8.3.1. North America
       8.3.2. Europe
       8.3.3. Asia Pacific
       8.3.4. Latin America
       8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis, by Region, 2015
8.5. Key Trends

Chapter 9. North America Single-use Bioprocessing Systems Market Analysis and Forecast
9.1. Key Findings
9.2. Introduction
9.3. Market Size (US$ Mn) Forecast, by Product 
       9.3.1. Bioreactors
       9.3.2. Mixers
       9.3.3. Bags
       9.3.4. Tubing
       9.3.5. Filtration Devices
       9.3.6. Bioprocess Containers
       9.3.7. Sampling Systems
       9.3.8. Connectors & Clamps
       9.3.9. Probes & Sensors
9.4. Market Size (US$ Mn) Forecast, by Application
       9.4.1. Monoclonal Antibody Production 
       9.4.2. Vaccine Production 
       9.4.3. Plant Cell Cultivation
       9.4.4. Patient Specific Cell Therapies
       9.4.5. Others (recombinant proteins, enzymes etc.)
9.5. Market Size (US$ Mn) Forecast, by Application
       9.5.1. Pharmaceutical
       9.5.2. Biotechnology 
       9.5.3. CRO & CMO 
       9.5.4. Academic & Research Institutes
9.6. Market Size (US$ Mn) Forecast, by Country
       9.6.1. U.S.
       9.6.2. Canada
9.7. Market Attractiveness Analysis, by Product, 2015
9.8. Market Attractiveness Analysis, by Application, 2015
9.9. Market Attractiveness Analysis, by End-user, 2015
9.10. Key Trends

Chapter 10. Single-use Bioprocessing Systems Market: Regional Snippets
10.1. Introduction
10.2. Europe Market Size (US$ Mn) Forecast, by Country 
       10.2.1. UK
       10.2.2. Germany
       10.2.3. France
       10.2.4. Italy 
       10.2.5. Rest of Europe
10.3. Asia Pacific Market Size (US$ Mn) Forecast, by Country
       10.3.1. China
       10.3.2. Japan
       10.3.3. Australia & New Zealand
       10.3.4. Rest of Asia Pacific
10.4. Latin America Market Size (US$ Mn) Forecast, by Country
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
10.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Country 
       10.5.1. UAE
       10.5.2. South Africa
       10.5.3. Rest of Middle East & Africa

Chapter 11. Competition Landscape
11.1. Single-use Bioprocessing Systems Market Share Analysis, Key Players, 2015 
11.2. Competition Matrix
11.3. Company Profiles
       11.3.1. Danaher Corporation (Pall Corporation) 
                 11.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 11.3.1.2. Financial Overview
                 11.3.1.3. Product Portfolio
                 11.3.1.4. SWOT Analysis
                 11.3.1.5. Strategic Overview
       11.3.2. Eppendorf AG
                 11.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 11.3.2.2. Financial Overview
                 11.3.2.3. Product Portfolio
                 11.3.2.4. SWOT Analysis
                 11.3.2.5. Strategic Overview
       11.3.3. Finesse Solutions
                 11.3.3.1. Company Overview (HQ, business segments, employee strength)
                 11.3.3.2. Financial Overview
                 11.3.3.3. Product Portfolio
                 11.3.3.4. SWOT Analysis
                 11.3.3.5. Breakdown of recent offices opened, by Region
                 11.3.3.6. Strategic Overview
       11.3.4. GE Healthcare
                 11.3.4.1. Company Overview (HQ, business segments, employee strength)
                 11.3.4.2. Financial Overview
                 11.3.4.3. Product Portfolio
                 11.3.4.4. SWOT Analysis
                 11.3.4.5. Strategic Overview
       11.3.5. Meissner Filtration Products, Inc.
                 11.3.5.1. Company Overview (HQ, business segments, employee strength)
                 11.3.5.2. Financial Overview
                 11.3.5.3. Product Portfolio
                 11.3.5.4. SWOT Analysis
                 11.3.5.5. Strategic Overview
       11.3.6. Merck KGaA (Merck Millipore)
                 11.3.6.1. Company Overview (HQ, business segments, employee strength)
                 11.3.6.2. Product Portfolio
                 11.3.6.3. SWOT Analysis
                 11.3.6.4. Recent Developments
                 11.3.6.5. Strategic Overview
       11.3.7. Parker Hannifin Corporation
                 11.3.7.1. Company Overview (HQ, business segments, employee strength)
                 11.3.7.2. Financial Overview
                 11.3.7.3. Product Portfolio
                 11.3.7.4. SWOT Analysis
                 11.3.7.5. Strategic Overview
       11.3.8. PBS Biotech, Inc.
                 11.3.8.1. Company Overview (HQ, business segments, employee strength)
                 11.3.8.2. Financial Overview
                 11.3.8.3. Product Portfolio
                 11.3.8.4. SWOT Analysis
                 11.3.8.5. Breakdown of Funding Received by PBS Biotech during establishment 
                 11.3.8.6. Strategic Overview
       11.3.9. Saint Gobain
                 11.3.9.1. Company Overview (HQ, business segments, employee strength)
                 11.3.9.2. Product Portfolio
                 11.3.9.3. SWOT Analysis
                 11.3.9.4. Strategic Overview
                 11.3.9.5. Value Chain
       11.3.10. Sartorius AG
                 11.3.10.1. Company Overview (HQ, business segments, employee strength)
                 11.3.10.2. Financial Overview
                 11.3.10.3. Product Portfolio
                 11.3.10.4. SWOT Analysis
                 11.3.10.5. Strategic Overview
       11.3.11. Sentinel Process Systems
                 11.3.11.1. Company Overview (HQ, business segments, employee strength)
                 11.3.11.2. Financial Overview
                 11.3.11.3. Product Portfolio
                 11.3.11.4. SWOT Analysis
                 11.3.11.5. Partnerships for single-use systems
                 11.3.11.6. Strategic Overview
       11.3.12. Thermo Fisher Scientific
                 11.3.12.1. Company Overview (HQ, business segments, employee strength)
                 11.3.12.2. Financial Overview
                 11.3.12.3. Product Portfolio
                 11.3.12.4. SWOT Analysis
                 11.3.12.5. Strategic Overview
       11.3.13. List of CMO’s & Suppliers in North America

List of Figures

Figure 1: Overview of Processes carried out using single-use bioprocessing systems
Figure 2: Global Single-use Bioprocessing Systems Average Price (US$/ Unit), 2015
Figure 3: North America Single-use Bioprocessing Systems Average Price (US$/ Unit) 2015
Figure 4: Standard Single-use Products Value Chain
Figure 5: Custom Single-use Products Value Chain
Figure 7: Global Single-use Bioprocessing Systems Market Value Share, by Application (2016)
Figure 9: Global Single-use Bioprocessing Systems Market Value Share, by End-user (2016)
Figure 6: Global Single-use Bioprocessing Systems Market Value Share, by Product (2016)
Figure 8: Global Single-use Bioprocessing Systems Market Value Share, by Region (2016)
Figure 10: Global Single-use Bioprocessing Systems Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 11: Global Bioreactors & Fermenters Market Revenue (US$ Mn), 2014–2024
Figure 12: Global Mixers Market Revenue (US$ Mn), 2014–2024
Figure 13: Global Bioprocessing Bags Market Revenue (US$ Mn), 2014–2024
Figure 14: Global Tubing Market Revenue (US$ Mn), 2014–2024
Figure 15: Global Filtration Devices Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Bioprocess Containers Market Revenue (US$ Mn), 2014–2024
Figure 17: Global Sampling Systems Market Revenue (US$ Mn), 2014–2024
Figure 18: Global Connectors & Clamps Market Revenue (US$ Mn), 2014–2024
Figure 19: Global Probes & Sensors Market Revenue (US$ Mn), 2014–2024
Figure 20: Single-use Bioprocessing Systems Market Attractiveness Analysis, by Product Type, 2015
Figure 21: Global Single-use Bioprocessing Systems Market Value Share Analysis, by Application, 2015 and 2024
Figure 22: Global Monoclonal Antibody Production Market Revenue (US$ Mn), 2014–2024
Figure 23: Global Vaccine Production Market Revenue (US$ Mn), 2014–2024
Figure 24: Global Plant Cell Cultivation Market Revenue (US$ Mn), 2014–2024
Figure 25: Global Patient Specific Cell Therapies Market Revenue (US$ Mn), 2014–2024
Figure 26: Global Others Market Revenue (US$ Mn) (US$ Mn), 2014–2024
Figure 27: Single-use Bioprocessing Systems Market Attractiveness Analysis, by Application, 2015
Figure 28: Global Single-use Bioprocessing Systems Market Value Share Analysis, by End-user, 2015 and 2024
Figure 29: Global Pharmaceutical Market Revenue (US$ Mn), 2014–2024
Figure 30: Global Biotechnology Market Revenue (US$ Mn), 2014–2024
Figure 31: Global CRO/CMO Market Revenue (US$ Mn), 2014–2024
Figure 32: Global Academic & Research Institutes Market Revenue (US$ Mn), 2014–2024
Figure 33: Single-use Bioprocessing Systems Market Attractiveness Analysis, by End-user, 2015
Figure 34: Global Single Use Bioprocessing Systems Market Revenue, US$ Mn, 2014-2024
Figure 35: Global Single-use Bioprocessing Systems Market Value Share Analysis, by Region, 2015 and 2024
Figure 36: Single-use Bioprocessing Systems Market Attractiveness Analysis, by Region, 2015
Figure 37: North America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, 2014–2024
Figure 38: North America Single-use Bioprocessing Systems Market Attractiveness Analysis, by Country, 2015
Figure 39: North America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 40: North America Market Value Share Analysis, by End-user, 2015 and 2024
Figure 41: North America Market Value Share Analysis, by Application, 2015 and 2024
Figure 42: North America Market Value Share Analysis, by Country, 2015 and 2024
Figure 43: North America Single-use Bioprocessing Systems Market Attractiveness Analysis, by Product Type, 2015
Figure 44: North America Single-use Bioprocessing Systems Market Attractiveness Analysis, by Application, 2015
Figure 45: North America Single-use Bioprocessing Systems Market Attractiveness Analysis, by End-user, 2015
Figure 46: Europe Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, 2014–2024
Figure 47: Asia Pacific Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, 2014–2024
Figure 48: Latin America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, 2014–2024
Figure 49: Middle East & Africa Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, 2014–2024
Figure 50: Global Single-use Bioprocessing Systems Market Share Analysis By Company (2015)

List of Tables

Table 1: System Comparison: Stainless Steel Vs. Single-use Systems
Table 2: Global Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Product Type, 2016–2024
Table 3: Global Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 4: Global Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 5: Global Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 6: North America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Product Type,
Table 7: North America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 8: North America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 9: North America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 10: Europe Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 11: Asia Pacific Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 12: Latin America Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 13: Middle East & Africa Single-use Bioprocessing Systems Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 14: List of CMO’s using Single-use Bioprocessing Systems
Table 15: List of Biopharmaceutical Manufacturers using Single-use Bioprocessing Systems
Table 16: List of additional Suppliers and Vendors for Single-use Bioprocessing Systems

Single-use Bioprocessing Systems Market: Trends and Opportunities

Bioprocessing is a significant part of biopharmaceutical development and production processes and single-use bioprocessing systems, which are meant for one-time use, have recently found their unique position in the biopharmaceutical and biotherapeutics industry. Biomanufacturing facilities which once housed only stainless steel equipment are paving the way for a hybrid setup which also incorporates single-use technologies. New facilities manufacturing biologics, especially CRO’s/CMO’s and small biotechnology startups are increasingly opting for fully single-use plants. These systems have made the production of clinical trial drugs as well as commercially manufactured drugs cost-effective and flexible. The market for single-use bioprocessing systems is expected to grow at a double-digit figure during the forecast period from 2016 to 2024 and shall be driven by factors such as lowered labor efforts, lowered capital cost, and riddance of time, money, and efforts spent on sterilization procedures.

Single-use Bioprocessing Systems Market: Scope and Methodology

This report on the global single-use bioprocessing systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, product innovation, expansion of infrastructural facilities by major and small pharmaceuticals, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global single-use bioprocessing systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Single-use Bioprocessing Systems Market: Segmentation

Based on product type, the global single-use bioprocessing systems market has been segmented into bioreactors and fermenters, mixers, bags, filtration devices, tubing, sampling systems, connectors & clamps, and sensors & probes. Bags and bioreactors are the most prominently selling products in the single-use bioprocessing systems market.

Major end-users of single-use bioprocessing systems include pharmaceutical organizations, biotechnology organizations, CRO’s & CMO’s, and academic and research institutes. In terms of applications, the market has been segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. The others segment includes recombinant proteins, enzymes, growth factors etc. The flexibility of single-use systems coupled with the decreased concern related to chances of cross contamination, make single-use bioprocessing systems a prime purchase option for manufacturers involved in monoclonal antibody production.

Geographically, the global single-use bioprocessing systems market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. A global overview has been provided, and the North America region has been analyzed in depth at country as well as product, application, and end-user segment level. The countries in North America section include the U.S. and Canada. The regions of Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. The countries include the U.K., Germany, France, Italy, China, Japan, Australia & New Zealand, Brazil, Mexico, the UAE, and South Africa.

Single-use Bioprocessing Systems Market: Competitive Landscape

The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the single-use bioprocessing systems market. The report also profiles major players in the single-use bioprocessing systems market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.

The global single-use bioprocessing systems market has been segmented as follows:

Global Single-use Bioprocessing Systems Market, by Product

  • Bioreactors & Fermenters
  • Mixers
  • Bags
  • Bioprocess Containers
  • Filtration Devices
  • Tubing
  • Sampling Systems
  • Connectors & Clamps
  • Probes & Sensors

Global Single-use Bioprocessing Systems Market, by End-user

  • Pharmaceutical
  • Biotechnology
  • CRO & CMO
  • Academic & Research Institutes 

Global Single-use Bioprocessing Systems Market, by Application

  • Monoclonal Antibody Production
  • Vaccine Production
  • Plant Cell Cultivation
  • Patient Specific Cell Therapies
  • Others (production of enzymes, growth factors etc.)

Global Single-use Bioprocessing Systems Market, by Geography

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • Rest of APAC
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top